TMEM164 and familial pancreatic carcinoma: also identified transmembrane protein 164 (TMEM164) as a key regulator of autophagy‐dependent ferroptosis, and the overexpression of TMEM164 is closely associated with the improvement of survival outcome and immune infiltration in patients with pancreatic cancer.